Literature DB >> 27595883

[Rare presentation of a scleral nevus with progression in size].

E J Schmitz1,2, M C Herwig3,4, F G Holz3, E Bierhoff5, K U Löffler3,4.   

Abstract

A 52-year-old male caucasian patient presented with a limbal subconjunctival pigmentation of unknown origin with progressive enlargement over the past years. Differential diagnoses included a malignant melanocytic lesion; therefore, an excisional biopsy was performed. Prior investigations showed no ciliary body or anterior chamber angle involvement. Histological and immunohistochemical analysis revealed the rare diagnosis of a scleral nevus. The clinical, histological and immunohistochemical findings as well as the relevant differential diagnoses are discussed.

Entities:  

Keywords:  Histology; Immunohistochemistry; Nevus; Oculodermal melanocytosis; Scleral pigmentation

Mesh:

Year:  2017        PMID: 27595883     DOI: 10.1007/s00347-016-0365-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

1.  Ocular and dermal melanocytosis.

Authors:  T B FITZPATRICK; H KITAMURA; A KUKITA; R ZELLER
Journal:  AMA Arch Ophthalmol       Date:  1956-12

2.  Nevus of Ota: morphological patterns and distribution in 47 Yemeni cases.

Authors:  M Alshami; M A Bawazir; A A Atwan
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-10-04       Impact factor: 6.166

3.  Ocular findings in oculodermal melanocytosis.

Authors:  C Teekhasaenee; R Ritch; U Rutnin; N Leelawongs
Journal:  Arch Ophthalmol       Date:  1990-08

4.  Management of conjunctival melanoma.

Authors:  Bertil Damato; Sarah E Coupland
Journal:  Expert Rev Anticancer Ther       Date:  2009-09       Impact factor: 4.512

5.  Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.

Authors:  Carol L Shields; Swathi Kaliki; Michael Livesey; Brianna Walker; Robert Garoon; Marissa Bucci; Eric Feinstein; Aline Pesch; Cristina Gonzalez; Sara E Lally; Arman Mashayekhi; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2013-08       Impact factor: 7.389

Review 6.  Tumors of the conjunctiva and cornea.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Surv Ophthalmol       Date:  2004 Jan-Feb       Impact factor: 6.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.